Join us for this live symposium offered in conjunction with the World Transplant Congress 2025, featuring two renowned kidney transplant experts.
Explore approaches to optimizing antiviral treatment of refractory CMV in SOT recipients.
NETs are a rare and diverse group of tumors that can arise throughout the neuroendocrine system, often presenting with a wide range of symptoms that make diagnosis and management complex.
Learn how to individualize CMV prevention in high-risk kidney transplant recipients, including selecting optimal antivirals and designing antiviral regimens to optimize patient outcomes.